======= KLF16 ======= == Gene Information == * **Official Symbol**: KLF16 * **Official Name**: Kruppel like factor 16 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83855|83855]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BXK1|Q9BXK1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KLF16&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KLF16|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606139|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that binds GC and GT boxes and displaces Sp1 and Sp3 from these sequences. Modulates dopaminergic transmission in the brain (By similarity). {ECO:0000250}. |zf-C2H2| |dopamine receptor signaling pathway| |cellular response to dopamine| |response to dopamine| |signal transduction involved in cellular response to ammonium ion| |cellular response to catecholamine stimulus| |cellular response to monoamine stimulus| |response to monoamine| |response to catecholamine| |cellular response to ammonium ion| |response to ammonium ion| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |cellular response to drug| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to organic cyclic compound| |cellular response to organonitrogen compound| |cellular response to nitrogen compound| |negative regulation of transcription by RNA polymerase II| |response to organic cyclic compound| |response to organonitrogen compound| |response to drug| |cellular response to oxygen-containing compound| |response to nitrogen compound| |negative regulation of transcription, DNA-templated| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-3.62| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-3.53| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.78| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.54| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.49| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-2.49| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.2| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.15| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.02| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.96| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.95| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.93| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-1.9| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.78| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-1.77| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.7| |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|1.72| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|1.73| |[[:results:exp461|BS-181 20μM R08 exp461]]|1.75| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.77| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.8| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.83| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.87| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.9| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|1.9| |[[:results:exp85|UM0129480 7μM R02 exp85]]|1.91| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|2| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.02| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.04| |[[:results:exp346|CoCl2 18μM R07 exp346]]|2.05| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.05| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|2.05| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.08| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|2.1| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|2.12| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.2| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.23| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.3| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|2.43| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|2.44| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|2.46| |[[:results:exp360|Genistein 15μM R07 exp360]]|2.58| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|2.64| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|2.68| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|2.72| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|2.72| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.72| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.76| |[[:results:exp433|LJH685 50μM R08 exp433]]|2.79| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.81| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|2.83| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.92| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|2.97| |[[:results:exp512|Olaparib 4μM R08 exp512]]|3.21| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|3.49| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|3.51| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.72| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|4.53| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|4.64| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|4.99| ^Gene^Correlation^ |[[:human genes:d:dlgap5|DLGAP5]]|0.5| |[[:human genes:t:tacc3|TACC3]]|0.448| |[[:human genes:d:dazap1|DAZAP1]]|0.418| |[[:human genes:l:lrrc8a|LRRC8A]]|0.417| |[[:human genes:k:kif15|KIF15]]|0.412| |[[:human genes:p:pmvk|PMVK]]|0.407| |[[:human genes:k:klf13|KLF13]]|0.405| |[[:human genes:a:aspm|ASPM]]|0.4| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5649 * **Expression level (log2 read counts)**: 5.86 {{:chemogenomics:nalm6 dist.png?nolink |}}